High-content monitoring of drug effects in a 3D spheroid model F Mittler, P Obeïd, AV Rulina, V Haguet, X Gidrol, MY Balakirev Frontiers in oncology 7, 293, 2017 | 150 | 2017 |
Wss1 metalloprotease partners with Cdc48/Doa1 in processing genotoxic SUMO conjugates MY Balakirev, JE Mullally, A Favier, N Assard, E Sulpice, DF Lindsey, ... Elife 4, e06763, 2015 | 80 | 2015 |
Activated leukemic oncogenes AML1-ETO and c-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition AV Rulina, PV Spirin, VS Prassolov Biochemistry (Moscow) 75, 1650-1666, 2010 | 34 | 2010 |
C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer XZ Liu, A Rulina, MH Choi, L Pedersen, J Lepland, ST Takle, ... Nature Communications 13 (1), 69, 2022 | 21 | 2022 |
Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference PV Spirin, D Baskaran, NN Orlova, AV Rulina, NA Nikitenko, ... Molecular biology 44, 776-786, 2010 | 19 | 2010 |
Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity AV Rulina, F Mittler, P Obeid, S Gerbaud, L Guyon, E Sulpice, ... Cell Death & Disease 7 (12), e2505-e2505, 2016 | 17 | 2016 |
High-content monitoring of drug effects in a 3D spheroid model. Front Oncol. 2017; 7: 293 F Mittler, P Obeïd, AV Rulina, V Haguet, X Gidrol, MY Balakirev | 7 | 2017 |
Mechanical stress shapes the cancer cell response to neddylation inhibition. BMY Mittler F, Obeïd P, Haguet V, Allier C, Gerbaud S, Rulina AV, Gidrol X J Exp Clin Cancer Res 41 (1), 115, 2022 | 6 | 2022 |
Cascade profiling of the ubiquitin-proteasome system in cancer A Rulina Université Grenoble Alpes, 2015 | | 2015 |